Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Bankiewicz
K S
KS
Surgical Neurology Branch, NINDS, National Institutes of Health, Bethesda, MD 20892.
Plunkett
R J
RJ
Mefford
I
I
Kopin
I J
IJ
Oldfield
E H
EH
D000313:Adrenal Medulla / Q000637:transplantation; D000650:Amnion / Q000637:transplantation; D000818:Animals; D016380:Brain Tissue Transplantation; D002421:Caudate Nucleus / Q000503:physiopathology*; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D004409:Dyskinesia, Drug-Induced / Q000134:cerebrospinal fluid / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D016332:Fetal Tissue Transplantation; D006085:Graft Survival; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D020267:MPTP Poisoning; D008253:Macaca mulatta; D008297:Male; D008636:Mesencephalon / Q000637:transplantation*; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D010300:Parkinson Disease / Q000601:surgery*; D014182:Transplantation, Autologous; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid